Indehaveren af markedsføringstilladelsen skal sikre, at farmakovigilanssystemet som beskrevet i ri
The MAH must ensure that the system of pharmacovigilance, as described in version 3.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and a